This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.In recent weeks, statements about the Israel-Hamas war have emerged from corporations of all kinds. Predictably, they have not all gone over well.

In the hours before Hurricane Otis made landfall, everything aligned to birth a beast. The hurricane, which arrived near Acapulco, Mexico, early this morning, had an improbable combination of terrible traits. It was small and nimble, as tropical storms go, which reduced the amount of data points available to forecasters and made it harder to track. It came toward land at night, which is the least ideal time for a chaos-inducing event to hit a population center.

President Joe Biden and his national-security team began their time in office in 2021 intending to concentrate on confronting China’s rise. The state of the world has not allowed such a singular focus. First came the American withdrawal from Afghanistan and the Taliban’s return to power. Next was Russia’s full-scale invasion of Ukraine.

Welcome to Up for Debate. Each week, Conor Friedersdorf rounds up timely conversations and solicits reader responses to one thought-provoking question. Later, he publishes some thoughtful replies. Sign up for the newsletter here.Last week, as observers characterized the recent attack on Israel as that country’s 9/11, I asked, “What did you learn from the September 11, 2001, terrorist attacks and America’s responses to them?”Replies have been edited for length and clarity.

Japan is home to an untold number of conveniences and delights that American consumers regularly go without: Faster public transit! Better sunscreen! Lychee KitKats! But as we head into sick season, one Japanese invention would be especially welcome on the U.S. market: an antiviral pill that appears to shorten COVID symptoms, might protect against chronic disease, and doesn’t taste like soapy grapefruit.